Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.
C KatlamaF BisshopJ BognerM J Pérez ElíasS Di GiambenedettoE ClarkeS HodderN NwokoloM Ait-KhaledJ OyeeR GroveB WynneC OkoliB JonesM KisarePublished in: HIV medicine (2024)
Results confirm the robustness of DTG/3TC as a switch option in virologically suppressed females with HIV-1, with outcomes similar to those in males.
Keyphrases
- hiv infected patients
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- electronic health record
- big data
- case control
- hiv testing
- hepatitis c virus
- clinical trial
- men who have sex with men
- machine learning
- data analysis
- metabolic syndrome
- insulin resistance
- phase iii
- open label
- deep learning
- adipose tissue